aspirin has been researched along with transforming growth factor beta in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Kumegawa, M; Kusaka, M; Oshima, T; Takai, T; Tanabe, T; Yamamoto, S; Yokoyama, C; Yoshimoto, T | 1 |
| Chauhan, A; Grace, AA; Grainger, DJ; Kemp, PR; Lawn, RM; Liu, AC; Metcalfe, JC; Schofield, PM; Williams, NR | 1 |
| Bignall, MC; Castor, CW; Hossler, PA; Smith, EM | 1 |
| Anastassiades, T; Chopra, R; Law, C; Wong, E | 1 |
| Jankowska, R; Kraus-Filarska, M; Małolepszy, J; Nadobna, G; Nowak, I; Zak-Nejmark, T | 1 |
| Ishibashi, R; Makino, H; Maruyama, T; Mori, K; Mukoyama, M; Muro, S; Nakao, K; Narumiya, S; Ohuchida, S; Suganami, T; Sugawara, A; Tanaka, I; Yahata, K | 1 |
| Del Rio, M; Ganado, P; García, M; Redondo, S; Rico, L; Santos-Gallego, CG; Tejerina, T | 1 |
| Fujinaga, Y; Makino, H; Mori, K; Mukoyama, M; Nakao, K; Suganami, T; Sugawara, A; Tanaka, I; Yahata, K; Yokoi, H | 1 |
| Dagher, Z; Gerhardinger, C; Lorenzi, M; Park, YS; Sebastiani, P | 1 |
| Gaikwad, AB; Mulay, SR; Tikoo, K | 1 |
| Bharti, AC; Kumar, A; Singh, SM; Tyagi, A; Vishvakarma, NK | 1 |
| Carlson, LM; Idborg, H; Jakobsson, PJ; Kogner, P; Rasmuson, A; Segerström, L; Sveinbjörnsson, B | 1 |
| Benjamim, CF; Canetti, C; Fierro, IM; Freire-de-Lima, CG; Guilherme, RF; Kunkel, SL; Neves, JS; Rocco, PR; Xisto, DG | 1 |
| Bordignon, J; Cecchini, R; da Silva, RV; de Freitas, RC; Goldenberg, S; Lovo-Martins, MI; Malvezi, AD; Martins-Pinge, MC; Neto, EC; Panis, C; Pinge-Filho, P; Tatakihara, VL; Yamada-Ogatta, SF; Zanluqui, NG | 1 |
| Banerjee, S; Banerjee, SK; Das, A; De, A; Maity, G; Sarkar, S | 1 |
| Arshi, S; Aryan, Z; Bemanian, MH; Esmaeilzadeh, H; Fallahpour, M; Mortazavi, N; Nabavi, M | 1 |
| Du, C; Liu, Y; Luo, F; Wang, Y; Zhang, N; Zhao, M | 1 |
| Achiche, J; Ahriz Saksi, S; Bailleul, S; Boulanger, H; Drouin, D; Dupuis, E; Ekoukou, D; Lefèvre, G; Sault, C; Stawiarski, N | 1 |
| Araújo-Silva, CA; Benjamim, CF; Blanco, PJ; Bulant, CA; Canetti, C; Fraga-Junior, VS; Guilherme, RF; Lemos, FS; Magalhães, NS; Moraes, JA; Nogueira, TO; Pecli, C; Scharfstein, J; Serra, R; Silva, JBNF; Svensjö, E; Waclawiack, I | 1 |
1 review(s) available for aspirin and transforming growth factor beta
| Article | Year |
|---|---|
[Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
Topics: Adult; Aspirin; Biomarkers; Endoglin; Endothelium, Vascular; Female; Humans; Immune Tolerance; Inflammation; Kidney Diseases; Kidney Transplantation; Membrane Proteins; Oxidative Stress; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; Prognosis; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2019 |
1 trial(s) available for aspirin and transforming growth factor beta
| Article | Year |
|---|---|
Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced; Desensitization, Immunologic; Double-Blind Method; Female; Humans; Interferon-gamma; Interleukin-10; Male; Nasal Polyps; Rhinitis; Sinusitis; Transforming Growth Factor beta; Treatment Outcome; Young Adult | 2015 |
17 other study(ies) available for aspirin and transforming growth factor beta
| Article | Year |
|---|---|
Induction of fatty acid cyclooxygenase in mouse osteoblastic cells (MC3T3-E1).
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Bucladesine; Cattle; Cell Line; Cyclic AMP; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Induction; Epidermal Growth Factor; Epinephrine; Mice; Osteoblasts; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Second Messenger Systems; Transforming Growth Factor beta | 1991 |
The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis.
Topics: Aged; Aspirin; Cholesterol, LDL; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Risk Factors; Transforming Growth Factor beta | 1995 |
Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network.
Topics: Arthritis, Rheumatoid; Aspirin; Cells, Cultured; Connective Tissue; Culture Media, Conditioned; Cytokines; Dinoprostone; DNA; Drug Synergism; Epidermal Growth Factor; Fibroblast Growth Factors; Glycosaminoglycans; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydrocortisone; Inflammation; Insulin-Like Growth Factor I; Interferon-gamma; Interleukin-6; Osteoarthritis; Peptides; Platelet-Derived Growth Factor; Recombinant Proteins; Synovial Membrane; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 1997 |
In vitro suppression of transforming growth factor-beta induced stimulation of glycosaminoglycan synthesis by acetylsalicylic acid and its reversal by misoprostol.
Topics: Animals; Aspirin; Cartilage, Articular; Cattle; Cells, Cultured; Chondrocytes; Glycosaminoglycans; Insulin-Like Growth Factor I; Misoprostol; Transforming Growth Factor beta | 1998 |
[Effects of anti-inflammatory drugs on adhesion and migration of lymphocytes].
Topics: Adult; Anti-Inflammatory Agents; Antigens, CD; Aspirin; Cell Adhesion; Cell Movement; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Lymphocytes; Male; Methotrexate; Reference Values; Transforming Growth Factor beta | 1999 |
Prevention of diabetic nephropathy in rats by prostaglandin E receptor EP1-selective antagonist.
Topics: Animals; Aspirin; Autocrine Communication; Cells, Cultured; Cinnamates; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dinoprostone; Disease Progression; Fibronectins; Glomerular Mesangium; Hypertrophy; Kidney; Kidney Glomerulus; Proteinuria; Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Tissue Distribution; Transforming Growth Factor beta; Up-Regulation | 2002 |
Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-beta.
Topics: Animals; Aspirin; Blotting, Northern; Cell Cycle; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; L-Lactate Dehydrogenase; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Rats; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
Topics: Animals; Aspirin; Blotting, Northern; Cells, Cultured; Connective Tissue Growth Factor; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Gene Expression Regulation; Glomerular Mesangium; Glucose; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Kidney Glomerulus; Kinetics; Male; Prostaglandins; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy.
Topics: Animals; Aspirin; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Gene Expression Profiling; Gene Expression Regulation; Imidazolidines; Inflammation; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rats; Receptors, Transforming Growth Factor beta; Retina; Retinal Vessels; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transforming Growth Factor beta | 2009 |
Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Benzimidazoles; Benzoates; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gene Expression Regulation; Inflammation; Male; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Streptozocin; Telmisartan; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2010 |
Anti-neoplastic action of aspirin against a T-cell lymphoma involves an alteration in the tumour microenvironment and regulation of tumour cell survival.
Topics: Administration, Oral; Animals; Apoptosis; Aspirin; Cell Cycle; Cell Death; Cell Survival; Cyclin B1; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; Hydrogen-Ion Concentration; Injections, Intralesional; Interferon-gamma; Interleukin-10; Interleukin-4; Interleukin-6; Lactic Acid; Lymphoma, T-Cell; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Transforming Growth Factor beta; Tumor Microenvironment | 2012 |
Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma.
Topics: Animals; Aspirin; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cytokines; Dendritic Cells; Disease Models, Animal; Disease Progression; Homozygote; Immunity, Innate; Inflammation; Macrophages; Mice; Mice, Transgenic; Neuroblastoma; Prostaglandin D2; Th2 Cells; Thromboxane A2; Transforming Growth Factor beta | 2013 |
Pulmonary antifibrotic mechanisms aspirin-triggered lipoxin A(4) synthetic analog.
Topics: Animals; Arginase; Aspirin; Biomarkers; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Count; Cytokines; Disease Models, Animal; Intercellular Signaling Peptides and Proteins; Lipoxins; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Peptides; Pulmonary Fibrosis; Pulmonary Surfactant-Associated Protein C; Respiratory Mechanics; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2013 |
Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Cell Line; Cell Survival; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Enzyme-Linked Immunosorbent Assay; Immunity, Innate; Immunohistochemistry; Interleukin-1beta; Myoblasts, Cardiac; Nitric Oxide; Pyrazoles; Rats; Sulfonamides; Transforming Growth Factor alpha; Transforming Growth Factor beta; Trypanosoma cruzi | 2014 |
Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition.
Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Breast Neoplasms; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Female; Humans; MCF-7 Cells; Mice, Nude; Transforming Growth Factor beta; Xenograft Model Antitumor Assays | 2015 |
Aspirin and metformin exhibit antitumor activity in murine breast cancer.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspirin; Breast Neoplasms; Cell Proliferation; Female; Humans; Hypoglycemic Agents; Metformin; Mice; Mice, Inbred BALB C; Mice, Nude; Signal Transduction; Transforming Growth Factor beta; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2018 |
Pleiotropic antifibrotic actions of aspirin-triggered resolvin D1 in the lungs.
Topics: Aspirin; Bleomycin; Docosahexaenoic Acids; Humans; Lung; Pulmonary Fibrosis; Transforming Growth Factor beta | 2023 |